LITTLE ROCK, Ark. (Medtronic) -- Hypoglycemia, or low blood sugar, can be life-threatening for people with type 1 diabetes, especially at night when they are likely to be unaware of any symptoms while they sleep.
Since the landmark DCCT trial, researchers and industry have focused on the challenge of reducing the risk of hypoglycemia while helping patients maintain good blood sugar control.
Published online in The New England Journal of Medicine (NEJM), and presented at the American Diabetes Association (ADA) Scientific Sessions, new study results report that an investigational Medtronic MiniMed integrated insulin pump with automatic insulin suspension (a feature called Threshold Suspend) safely reduced nocturnal hypoglycemia without increasing A1C (average blood glucose).
Dr. Thrasher from the Arkansas Diabetes Clinic and Research Center in Little Rock was one of the researchers in this study - the first, large in-home study to show the results of the integrated system when Threshold Suspend, which is unique to the MiniMed insulin pump system, is incorporated.
Here is a link to a press release about the results: http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=1832103&highlight